BiotechTube

Nasal Glucagon 1 mg + Nasal Glucagon 2 mg + SC Glucagon + Nasal Glucagon 3 mg

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypoglycemia

Conditions

Hypoglycemia

Trial Timeline

Mar 1, 2012 → Jul 1, 2012

NCT ID
NCT01556594

About Nasal Glucagon 1 mg + Nasal Glucagon 2 mg + SC Glucagon + Nasal Glucagon 3 mg

Nasal Glucagon 1 mg + Nasal Glucagon 2 mg + SC Glucagon + Nasal Glucagon 3 mg is a phase 2 stage product being developed by Eli Lilly for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01556594. Target conditions include Hypoglycemia.

What happened to similar drugs?

2 of 14 similar drugs in Hypoglycemia were approved

Approved (2) Terminated (0) Active (12)
✅Sitagliptin phosphate + PlaceboMerckApproved
✅PramlintideBristol Myers SquibbApproved
🔄Nasal GlucagonEli LillyPhase 3
🔄Nasal GlucagonEli LillyPhase 3
🔄DasiglucagonNovo NordiskPhase 3
🔄dasiglucagon + placebo + GlucaGen HypoKitZealand PharmaPhase 3
🔄Dasiglucagon + PlaceboZealand PharmaPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01556594Phase 2Completed

Competing Products

20 competing products in Hypoglycemia

See all competitors
ProductCompanyStageHype Score
MBX 1416 (INN imapextide)MBX BiosciencesPhase 2
36
MBX 1416 (Part A) + MBX 1416 (Part B) + Placebo + MBX 1416 (Part C)MBX BiosciencesPhase 1
23
Nasal GlucagonEli LillyPhase 3
40
Glucagon + InsulinAbvance TherapeuticsPhase 1
19
Nasal Glucagon + Intramuscular GlucagonEli LillyPhase 1
29
Nasal GlucagonEli LillyPhase 3
40
Eplerenone + PlaceboJohnson & JohnsonPre-clinical
26
Sitagliptin phosphate + PlaceboMerckApproved
43
PasireotideNovartisPhase 1
29
DasiglucagonNovo NordiskPhase 3
40
Glucagen + Mayne GlucagonPfizerPhase 1
29
PramlintideBristol Myers SquibbApproved
43
dasiglucagon + placebo + GlucaGen HypoKitZealand PharmaPhase 3
37
Dasiglucagon + PlaceboZealand PharmaPhase 1
26
Dasiglucagon + Dasiglucagon + PlaceboZealand PharmaPhase 2
24
ZP4207 + GlucagonZealand PharmaPhase 1
26
ZP4207 + PlaceboZealand PharmaPhase 1
26
Dasiglucagon + PlaceboZealand PharmaPhase 3
37
dasiglucagon + GlucaGenZealand PharmaPhase 3
37
Dasiglucagon + PlaceboZealand PharmaPhase 2
32